Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques

Overview

About this study

The purpose of this study is to assess the severity of tricuspid regurgitation (a disorder in which the tricuspid valve in your heart does not close tight enough) using cardiac magnetic resonance imaging (MRI).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Moderate or more tricuspid regurgitation.

Exclusion Criteria:

Prior tricuspid valve prosthesis.
Pacemaker/defibrillator that would impede MRI imaging.
Planned tricuspid valve surgery.
Primary liver pathology.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Mohamad Adnan Alkhouli, M.D., M.B.A.	Closed for enrollment	Contact information: Agata Sularz M.B., B.Chir. (507) 255-9117 Sularz.Agata@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mohamad Adnan Alkhouli, M.D., M.B.A.

Closed for enrollment

Contact information:

Agata Sularz M.B., B.Chir.

(507) 255-9117

Sularz.Agata@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials